Aesthetics Journal

Latest features

Merz Aesthetics explores its special partnership between two leading aesthetic distributors

Consultant plastic, reconstructive and aesthetic surgeon Mr Dalvi Humzah outlines the development of new and existing toxins

Botulinum Toxin Update

By Mr Dalvi Humzah

Consultant plastic, reconstructive and aesthetic surgeon Mr Dalvi Humzah outlines the development of new and existing toxins
ACE 2019: Another Fantastic Year

Following our most successful conference and exhibition to date, Aesthetics reflects on the biggest weekend of 2019.

Pain Management in Aesthetics

Dr Lee Walker outlines the possible strategies for managing patient pain for aesthetic procedures
Facial Hyperhidrosis

Ms Natasha Berridge and Mr Mahesh Kumar discuss the recognition, diagnosis and management of facial hyperhidrosis
Botulinum Neurotoxin Formulations

Dr Souphiyeh Samizadeh explores the science and pharmacological differences of botulinum neurotoxin formulations

Evolus announces US consumer campaign to promote Jeuveau

US-based medical aesthetic company Evolus Inc has begun a consumer campaign in the US called ‘#NEWTOX NOW’ in the hope to encourage patients to use its botulinum toxin.
Study demonstrates high patient satisfaction with Azzalure

The results of two studies conducted by pharmaceutical company Galderma (UK) Limited have demonstrated high patient satisfaction for the use of Azzalure (AbobotulinumtoxinA), its botulinum toxin type A product, in the glabellar complex.